Industrial Internet of things - IIOT
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models. Born out of the Internet framework, this new renaissance is termed as the Industrial Internet of Things- symbolising the complex network of assets, processes and people in future factories. This will begin a new era of connectivity, convergence and mobility, where data will gain centrestage and become the new capital for intelligence. Data-driven business models will disrupt conventional product markets and lead to the consolidation and reinvention of new approaches in future factories. The trend of IIoT, in effect, will become the common underlying denominator governing all future transformation in the manufacturing world
Frost & Sullivan’s IIoT research and consulting programs are focussed on foreseeing the impact of advanced IoT technologies within the manufacturing sector. The research approach is formulated with a specific objective of trying to predict how connectivity and data analytics will influence the reinvention of existing industrial supplier markets. This is achieved via a thematic approach that is detailed below.
IT-OT convergence
Services 2.0 (advanced services)
Supply chain evolution
Industry 4.0 business ecosystem
Additive manufacturing
Industrial Robotics
Big data analytics
We work closely with the world’s leading industrial companies, manufacturers, information and communication technology (ICT) vendors, measurement and instrumentation vendors to build customized deliverables that can aid in strategic decision making. The insight from this research program is tuned to be applicable for multiple industries and supports client in the creation of an effective IIOT strategy
-
27 Jun 2019 | North America | Technology Research
Internet-delivered Therapies and Mobile Health Ushering a New Health Paradigm
Redefining the Future of Healthcare by Providing Remote, Timely, Patient-Specific Healthcare Interventions
The mobile and wireless technologies have revolutionized the healthcare service delivery across the globe. Mobile and Internet based healthcare therapies and services in form of patient monitoring devices or personal digital assistants provide great connectivity and convenience. This research service (RS) showcases the innovations in digital and mo...
$4,950.00 -
28 Jun 2019 | North America | Technology Research
HealthWear Enabling Continuous Monitoring and Remote Therapies
Technology Advances Improving the Management of Chronic Diseases Including Diabetes and Neurological Conditions
Currently there is a huge demand for healthcare services outside the hospitals and clinics, into the home environment, with healthwear meeting the needs of this growing trend and demand. The wearable medical devices integrated with vital signs or motion sensors can be used for continuous remote monitoring of patients, especially vulnerable chronic ...
$4,950.00 -
31 Jan 2020 | North America | Market Research
Predictions for the Global Life Sciences Industry, 2020
COVID-19 Pandemic will Drive New Digital-tech Adoption in Drug Discovery and Testing Services, and Federal Funding will Encourage Stronger Product Pipelines
The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...
$1,500.00 -
23 Oct 2020 | North America | Market Research
Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026
Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities
In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...
$4,950.00 -
30 Apr 2021 | North America | Market Research
Internet of Things (IoT) Based Technologies and Patient Preference to Drive Growth of the Global Home Healthcare Solutions Market, 2025
Future Growth Potential to be Accelerated by Reforms in Payment and Reimbursement Policies
As per medicare.gov, home healthcare is defined as a wide range of healthcare services that can be given at home for an illness or injury. Home healthcare is usually less expensive, more convenient, and just as effective as the care provided in a hospital or Skilled Nursing Facility (SNF). Presently, home healthcare has evolved to also cater to pre...
$4,950.00 -
27 Aug 2021 | North America | Market Research
US and EU Upstream Bioprocessing Growth Opportunities
Increasing Demand for Consumables and Single-use Technologies to Drive Growth in Upstream Bioprocessing
The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...
$4,950.00 -
24 Jan 2023 | North America | Market Research
US Healthcare Claims Management Growth Opportunities
Intelligent Tools to Automate Payer and Provider Functions Will Boost Efficiency and Deliver a Digital Customer Experience
The healthcare claims management industry is evolving. Changes include a shifting reimbursement landscape (for virtual care, urgent care, telehealth, and at-home care); a transition to new, value-based care models (e.g., population-based reimbursement and partial and full capitation payment); and disruption from big tech companies, big-box retailer...
$4,950.00 -
03 Feb 2023 | North America | Market Research
Global Pharmaceutical Continuous Manufacturing Market, Growth Opportunities
Regulatory Acceptance Propelling Continuous Manufacturing Investments through Partnerships and In-house Expansions
Continuous manufacturing (CM) is a method for manufacturing end-to-end pharmaceutical products on a single, uninterrupted production line. While batch manufacturing requires transporting, testing, and refeeding materials from one process to the next, continuous processes execute all testing, feeding, and processing inline at a single manufacturing ...
$4,950.00
